What Happened?

Shares of medical device company CooperCompanies (NASDAQ:COO) fell 8.1% in the pre-market session after the company reported weak fourth quarter results: revenue missed, which is never a good sign. EPS was in line while the company reiterated full-year sales guidance. Markets typically reward companies that beat and raise guidance. Overall, the results could have been better.

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy CooperCompanies? Access our full analysis report here, it’s free.

What The Market Is Telling Us

CooperCompanies’s shares are not very volatile and have only had 2 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.

CooperCompanies is down 7.5% since the beginning of the year, and at $83.81 per share, it is trading 24.7% below its 52-week high of $111.23 from September 2024. Investors who bought $1,000 worth of CooperCompanies’s shares 5 years ago would now be looking at an investment worth $1,057.

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.